The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Trypanosomiasis, African

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Trypanosomiasis, African

 

High impact information on Trypanosomiasis, African

 

Chemical compound and disease context of Trypanosomiasis, African

 

Biological context of Trypanosomiasis, African

 

Anatomical context of Trypanosomiasis, African

 

Gene context of Trypanosomiasis, African

 

Analytical, diagnostic and therapeutic context of Trypanosomiasis, African

References

  1. Pentamidine for the treatment of Pneumocystis carinii pneumonia and other protozoal diseases. Pearson, R.D., Hewlett, E.L. Ann. Intern. Med. (1985) [Pubmed]
  2. African trypanosomiasis in an American hunter in East Africa. Quinn, T.C., Hill, C.D. Arch. Intern. Med. (1983) [Pubmed]
  3. Inhibition of myotoxic activity of Bothrops asper myotoxin II by the anti-trypanosomal drug suramin. Murakami, M.T., Arruda, E.Z., Melo, P.A., Martinez, A.B., Calil-Eliás, S., Tomaz, M.A., Lomonte, B., Gutiérrez, J.M., Arni, R.K. J. Mol. Biol. (2005) [Pubmed]
  4. Human macrophage tumor necrosis factor (TNF)-alpha production induced by Trypanosoma brucei gambiense and the role of TNF-alpha in parasite control. Daulouède, S., Bouteille, B., Moynet, D., De Baetselier, P., Courtois, P., Lemesre, J.L., Buguet, A., Cespuglio, R., Vincendeau, P. J. Infect. Dis. (2001) [Pubmed]
  5. Inhibition of Trypanosoma cruzi hexokinase by bisphosphonates. Hudock, M.P., Sanz-Rodríguez, C.E., Song, Y., Chan, J.M., Zhang, Y., Odeh, S., Kosztowski, T., Leon-Rossell, A., Concepción, J.L., Yardley, V., Croft, S.L., Urbina, J.A., Oldfield, E. J. Med. Chem. (2006) [Pubmed]
  6. CD8 is critically involved in lymphocyte activation by a T. brucei brucei-released molecule. Olsson, T., Bakhiet, M., Höjeberg, B., Ljungdahl, A., Edlund, C., Andersson, G., Ekre, H.P., Fung-Leung, W.P., Mak, T., Wigzell, H. Cell (1993) [Pubmed]
  7. Arsenical-resistant trypanosomes lack an unusual adenosine transporter. Carter, N.S., Fairlamb, A.H. Nature (1993) [Pubmed]
  8. Polyamines as targets for therapeutic intervention. Marton, L.J., Pegg, A.E. Annu. Rev. Pharmacol. Toxicol. (1995) [Pubmed]
  9. Identification of a novel prostaglandin f(2alpha) synthase in Trypanosoma brucei. Kubata, B.K., Duszenko, M., Kabututu, Z., Rawer, M., Szallies, A., Fujimori, K., Inui, T., Nozaki, T., Yamashita, K., Horii, T., Urade, Y., Hayaishi, O. J. Exp. Med. (2000) [Pubmed]
  10. Eflornithine for African sleeping sickness. Sjoerdsma, A., Schechter, P.J. Lancet (1999) [Pubmed]
  11. Suramin/metronidazole combination for African sleeping sickness. Raseroka, B.H., Ormerod, W.E. Lancet (1985) [Pubmed]
  12. Efficacy of combinations of difluoromethylornithine and bleomycin in a mouse model of central nervous system African trypanosomiasis. Clarkson, A.B., Bacchi, C.J., Mellow, G.H., Nathan, H.C., McCann, P.P., Sjoerdsma, A. Proc. Natl. Acad. Sci. U.S.A. (1983) [Pubmed]
  13. Galactose metabolism is essential for the African sleeping sickness parasite Trypanosoma brucei. Roper, J.R., Guther, M.L., Milne, K.G., Ferguson, M.A. Proc. Natl. Acad. Sci. U.S.A. (2002) [Pubmed]
  14. Herbicides to curb human parasitic infections: in vitro and in vivo effects of trifluralin on the trypanosomatid protozoans. Chan, M.M., Grogl, M., Chen, C.C., Bienen, E.J., Fong, D. Proc. Natl. Acad. Sci. U.S.A. (1993) [Pubmed]
  15. Genetics of resistance to the African trypanosomes. VII. Trypanosome virulence is not linked to variable surface glycoprotein expression. Inverso, J.A., De Gee, A.L., Mansfield, J.M. J. Immunol. (1988) [Pubmed]
  16. Effects of trypanocidal drugs on protein biosynthesis in vitro and in vivo by Trypanosoma cruzi. Gonzalez, N.S., Cazzulo, J.J. Biochem. Pharmacol. (1989) [Pubmed]
  17. The parasite-specific trypanothione metabolism of trypanosoma and leishmania. Krauth-Siegel, R.L., Meiering, S.K., Schmidt, H. Biol. Chem. (2003) [Pubmed]
  18. Relationship of plasma growth hormone to slow-wave sleep in African sleeping sickness. Radomski, M.W., Buguet, A., Doua, F., Bogui, P., Tapie, P. Neuroendocrinology (1996) [Pubmed]
  19. Relevance of autoantigens to autoimmunity in African trypanosomiasis: study of DNA and thyroglobulin antibodies. Daniel-Ribeiro, C., Tirard, S., Monjour, L., Homberg, J.C., Gentilini, M. Acta Trop. (1983) [Pubmed]
  20. Experimental African trypanosomiasis: a subset of pathogenic, IFN-gamma-producing, MHC class II-restricted CD4+ T cells mediates early mortality in highly susceptible mice. Shi, M., Wei, G., Pan, W., Tabel, H. J. Immunol. (2006) [Pubmed]
  21. Nitric oxide and cytokine synthesis in human African trypanosomiasis. MacLean, L., Odiit, M., Sternberg, J.M. J. Infect. Dis. (2001) [Pubmed]
  22. Correlation of autoantibody titres with central nervous system pathology in experimental African trypanosomiasis. Hunter, C.A., Jennings, F.W., Tierney, J.F., Murray, M., Kennedy, P.G. J. Neuroimmunol. (1992) [Pubmed]
  23. Constitutive and inflammatory induction of alpha and beta chemokines in human first trimester forebrain astrocytes and neurons. Bakhiet, M., Mousa, A., Seiger, A., Andersson, J. Mol. Immunol. (2002) [Pubmed]
  24. Innate resistance to experimental African trypanosomiasis: differences in cytokine (TNF-alpha, IL-6, IL-10 and IL-12) production by bone marrow-derived macrophages from resistant and susceptible mice. Kaushik, R.S., Uzonna, J.E., Zhang, Y., Gordon, J.R., Tabel, H. Cytokine (2000) [Pubmed]
  25. Comparison of cytokine plasma levels in human African trypanosomiasis. Courtin, D., Jamonneau, V., Mathieu, J.F., Koffi, M., Milet, J., Yeminanga, C.S., Kumeso, V.K., Cuny, G., Bilengue, C.M., Garcia, A. Trop. Med. Int. Health (2006) [Pubmed]
  26. Interest of tumor necrosis factor-alpha -308 G/A and interleukin-10 -592 C/A polymorphisms in human African trypanosomiasis. Courtin, D., Argiro, L., Jamonneau, V., N'dri, L., N'guessan, P., Abel, L., Dessein, A., Cot, M., Laveissiere, C., Garcia, A. Infect. Genet. Evol. (2006) [Pubmed]
  27. Clinical and neuroinflammatory responses to meningoencephalitis in substance P receptor knockout mice. Kennedy, P.G., Rodgers, J., Bradley, B., Hunt, S.P., Gettinby, G., Leeman, S.E., de Felipe, C., Murray, M. Brain (2003) [Pubmed]
  28. Experimental African trypanosomiasis: IFN-gamma mediates early mortality. Shi, M., Pan, W., Tabel, H. Eur. J. Immunol. (2003) [Pubmed]
  29. Structure of mammalian ornithine decarboxylase at 1.6 A resolution: stereochemical implications of PLP-dependent amino acid decarboxylases. Kern, A.D., Oliveira, M.A., Coffino, P., Hackert, M.L. Structure (1999) [Pubmed]
  30. Evaluation of the micro-CATT, CATT/Trypanosoma brucei gambiense, and LATEX/T b gambiense methods for serodiagnosis and surveillance of human African trypanosomiasis in West and Central Africa. Truc, P., Lejon, V., Magnus, E., Jamonneau, V., Nangouma, A., Verloo, D., Penchenier, L., Büscher, P. Bull. World Health Organ. (2002) [Pubmed]
  31. Interactions between immunity and chemotherapy in the treatment of the trypanosomiases and leishmaniases. Berger, B.J., Fairlamb, A.H. Parasitology (1992) [Pubmed]
  32. Affinity chromatography using trypanocidal arsenical drugs identifies a specific interaction between glycerol-3-phosphate dehydrogenase from Trypanosoma brucei and Cymelarsan. Denise, H., Giroud, C., Barrett, M.P., Baltz, T. Eur. J. Biochem. (1999) [Pubmed]
  33. Megazol combined with suramin: a chemotherapy regimen which reversed the CNS pathology in a model of human African trypanosomiasis in mice. Enanga, B., Keita, M., Chauvière, G., Dumas, M., Bouteille, B. Trop. Med. Int. Health (1998) [Pubmed]
  34. Interferon-gamma and interleukin-12 genes are preferentially expressed during early experimental African trypanosomiasis and suppressed by denervation of the spleen. Liu, Y., Ragaa, E., Li, Z., Nuortio, L., Mustafa, A., Bakhiet, M. Scand. J. Immunol. (1999) [Pubmed]
 
WikiGenes - Universities